Open access
ERK5 inhibition triggers CDK6 proteasomal degradation and enhances palbociclib efficacy in cancer cells
Claudia Faundez-Vidiella
Ylenia Sfragano
I. Tusa
Barbara Stecca
Sergio Espinosa-Gil
J. Lizcano
E. Rovida
Biology